Endomorphin-1 improves scopolamine-induced impairment of short-term memory via μ1-opioid receptor in mice
Authors:
- Toshinori KatohTKToshinori Katoh
- Takayoshi MamiyaTMTakayoshi Mamiya
- 1 December 2001
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 12 (17) , 3723-3727
Abstract
The effects of intracerebroventricular injection of endomorphin-1 and 2, endogenous mu-opioid receptor agonists, on the scopolamine-induced impairment of spontaneous alternation performance associated with short-term memory were investigated in mice. Endomorphin-1 (0.03 microg) inhibited scopolamine (1 mg/kg)-induced impairment of spontaneous alternation performance without affecting total arm entries, while endomorphin-2 (0.01-10 microg) failed to significantly influence the scopolamine (1 mg/kg)-induced impairment. Endomorphin-1 (0.03 microg) itself had no marked effects on spontaneous alternation performance in intact mice. Although beta-funaltrexamine (5 microg), a mu-opioid receptor antagonist, did not significantly affect the inhibitory effects of endomorphin-1 (0.03 microg) on the scopolamine (1 mg/kg)-induced impairment, naloxonazine (35 mg/kg), a mu1-opioid receptor antagonist, significantly reversed the inhibitory effects of endomorphin-1 (0.03 microg) on the impairment. Naloxonazine (35 mg/kg) unlike beta-funaltrexamine (5 microg) did not significantly influence the scopolamine (1 mg/kg)-induced impairment of spontaneous alternation performance. These results suggest that endomorphin-1 improves the disturbance of short-term memory resulting from cholinergic dysfunction through the mediation of mu1-opioid receptors.Keywords
This publication has 11 references indexed in Scilit:
- Endomorphins 1 and 2, endogenous μ-opioid receptor agonists, impair passive avoidance learning in miceEuropean Journal of Pharmacology, 2001
- Effects of endomorphins-1 and -2, endogenous μ-opioid receptor agonists, on spontaneous alternation performance in miceEuropean Journal of Pharmacology, 2000
- Differential distribution of endomorphin 1‐ and endomorphin 2‐like immunoreactivities in the CNS of the rodentJournal of Comparative Neurology, 1999
- Endomorphin-1 and endomorphin-2 are partial agonists at the human μ-opioid receptorEuropean Journal of Pharmacology, 1998
- The Endogenous Mu-Opioid Receptor Agonists Endomorphins 1 and 2 Have Novel Hypotensive Activity in the RabbitBiochemical and Biophysical Research Communications, 1997
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Effect of selective opiate antagonists on striatal acetylcholine and dopamine releaseBrain Research Bulletin, 1992
- Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: Reversal with glucose and with cholinergic and adrenergic agonists.Behavioral Neuroscience, 1991
- Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasksNeuropharmacology, 1990
- Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist ?-carbolinesPsychopharmacology, 1988